(Q33720053)

28 July 2017

1 reference

title

The role of glycopeptide antibiotics in the treatment of infective endocarditis (English)

1 reference

28 July 2017

main subject

infective endocarditis

1 reference

8

Pittet D

1 reference

28 July 2017

Grüneberg RN

1

1 reference

28 July 2017

Antunes F

2

1 reference

28 July 2017

Chambers HF

3

1 reference

28 July 2017

Garau J

4

1 reference

28 July 2017

Graninger W

5

1 reference

28 July 2017

Menichetti F

6

1 reference

28 July 2017

Peetermans WE

7

1 reference

28 July 2017

Shah PM

9

1 reference

28 July 2017

Vogelaers D

10

1 reference

28 July 2017

publication date

1 August 1999

1 reference

International Journal of Antimicrobial Agents

28 July 2017

published in

1 reference

28 July 2017

volume

12

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

191-198

1 reference

Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Characteristics of infective endocarditis in France in 1991. A 1-year survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Factors influencing mortality from infective endocarditis in two district general hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Risk factors for the development of prosthetic valve endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Fifty cases of late prosthetic valve endocarditis: improvement in prognosis over a 15 year period

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Recommendations for the treatment of infectious endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Experimental endocarditis: a review of its relevance to human endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Activity of teicoplanin in localized experimental infections in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Serum bactericidal titer as a predictor of outcome in endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

The phannacokinetics and extravascular diffusion of teicoplanin in rabbits and comparative efficacy with vancomycin in an experimental endocarditis model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Teicoplanin and rifampicin singly and in combination in the treatment of experimental Staphylococcus epidermidis endocarditis in the rabbit model.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Protein binding and serum bactericidal activities of vancomycin and teicoplanin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Teicoplanin in the treatment of gram-positive-bacterial endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Teicoplanin in endocarditis: a multicentre, open European study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

A critical review of the dosage of teicoplanin in Europe and the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Right-sided endocarditis caused by Staphylococcus aureus in drug abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Group of Experts of the International Society for Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900006-0

7 January 2021

10.1016/S0924-8579(99)00006-0

Identifiers

DOI

1 reference

28 July 2017

1 reference